Near-Term Targets: Envision Pharma Group Ltd commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2030 from a 2022 base year. Envision Pharma Group Ltd also commits to reduce scope 3 GHG emissions from business travel 52% per FTE by 2030 from a 2023 base year. Envision Pharma Group Ltd further commits that 75% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution will have science-based targets by 2028.